Navigation Links
Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
Date:2/11/2008

ans on the importance of treating

I.V. pain and on the features and use of Zingo for their pediatric

patients. These initiatives will be complemented by Zingo co-promotion

and distribution partner Sagent Pharmaceuticals' representatives, who

will work primarily with hospital pharmacies.

-- Launched two initiatives aimed to improve peripheral venous access pain

management in children: RN VOICE (Registered Nurses for Venipuncture

Optimization through Increased Comfort and Education), a

multidisciplinary group of healthcare professionals led by nurses to

facilitate better management of venous access pain; and

http://www.manageIVpain.com, an interactive Web site designed for

parents and healthcare providers seeking to better manage peripheral

venous access pain in children.

-- Proceeded with plans to file a supplemental New Drug Application with

the FDA in the first quarter of 2008 to expand the Zingo label to

include adults, based on successful pivotal Phase 3 trial in

approximately 700 adult patients.

-- Signed exclusive license agreement with Sigma-Tau SpA for the marketing

and distribution of Zingo in six European countries: Italy, France,

Germany, Netherlands, Belgium and Luxembourg. Sigma-Tau will oversee

all necessary regulatory filings, and will be responsible for all

marketing and sales of Zingo in their territory.

-- Granted an exclusive license to Medical Futures, Inc. for the marketing

and distribution of Zingo in Canada. Under the terms of the license,

Medical Futures will be responsible for all regulatory filings,

marketing, distribution and sales in Canada.

-- Conducted webcast and briefing in New York City with financial analysts

and major investors to present plans for
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Anesiva Appoints Daniel Janney to Board of Directors
2. Anesiva Announces Fourth Quarter and Year End 2007 Financial Results Conference Call and February 2008 Conference Participation
3. Anesiva Announces Completion of Common Stock Offering
4. Anesiva Raises $45 Million in Common Stock Offering
5. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
6. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
7. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
8. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
9. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... WI (PRWEB) , ... September 01, 2015 , ... In ... Venice expertly transports the reader to a not-so-distant future faced with an Ebola pandemic ... beautiful professional who overcomes personal tragedy to enter the world of counterterrorism, and who ...
(Date:9/1/2015)... ... September 01, 2015 , ... VetStem Biopharma announces new Clinical ... joint problems can be caused by injuries and abnormalities of the cervical spine. ... or of the spinal cord itself. This can manifest itself as any or ...
(Date:9/1/2015)... ... September 01, 2015 , ... Leading CEOs, ... and pain management space join prominent academics and key investors for Neuro Advance ... Medical School in Boston. , Neuro Advance Boston focuses on the latest ...
(Date:9/1/2015)... N.C. , Sept. 1, 2015   ... to facilitating the relationship between doctors and patients, ... Durham, N.C. -based venture capital ... strength and business association with Bull City Venture ... Malik , Medfusion Founder and Executive Chairman. "Both ...
Breaking Biology Technology:Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 3VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 2VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 3Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School 2Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 2Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 3
... thanks to a nanocoating, adjust their level of transparency ... energy; novel diagnostic methods and tailor-made nano-medicines to treat ... can be used to make very efficient dust filters ... vineyards from insect attack; new nanostructured materials for making ...
... May 27, 2011 Today BioSpace, the leading ... the 2011-2012 BioCapital™ Hotbed Campaign, marking the campaign,s ... The campaign highlights companies in the Mid-Atlantic ... participating companies are included on an electronic and ...
... designed for repairing damaged human tissue doesn,t wrinkle up ... the University of California, San Diego marks a significant ... the properties of native human tissue. Shaochen ... UC San Diego Jacobs School of Engineering, hopes future ...
Cached Biology Technology:A world without nano? Soon hard to imagine 2A world without nano? Soon hard to imagine 3Nanoengineers invent new biomaterial that more closely mimics human tissue 2
(Date:8/28/2015)... India , August 28, 2015 ... Assessment and Training Market by Assessment Type (Pen & ... Learning, Brain Training, Corporate Learning, Academic Research), Vertical and ... Cognitive Assessment and Training Market to grow from USD ... 2020, at a Compound Annual Growth Rate (CAGR) of ...
(Date:8/24/2015)... August 24, 2015 The consulting company ... largest biometrics manufacturer DERMALOG and its customized solutions and products ... Biometrics Company of the Year Award". DERMALOG is particularly successful ... .   -Cross reference: Picture is available at ... On Thursday evening, in South Africa,s ...
(Date:8/20/2015)... SANTA CLARA, Calif. , Aug. 20, 2015 ... based company focused on improving the user experience ... voice and vision technologies, today announced that its ... and voice biometric authentication software to be ... Alliance tested TrulySecure for compliance with the FIDO ...
Breaking Biology News(10 mins):Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5
... a mechanism that regulates the way an internal organelle, ... according to a report in Science Express. , ... and his colleagues at Yale study Trypanosoma brucei, the ... is exceptionally streamlined and has only one of each ...
... old. Really old, in fact, which comes as a surprise ... growth in the world's largest tropical region. , Using radiocarbon ... found that up to half of all trees greater than ... Some of the trees, Trumbore said, are as much as ...
... starting treatment with an antidepressant medication during the fall ... fall and winter months, reports a study in the ... the Society of Biological Psychiatry, published by Elsevier, a ... first systematic studies that indicate that SAD can actually ...
Cached Biology News:Sleeping sickness parasite shows how cells divide their insides 2Amazon trees much older than assumed, raising questions on global climate impact of region 2In SAD patients, autumn antidepressants can prevent winter depression 2
ABCA1 Immunogen: Mouse ABCA1-expressing HeLa stable transfectants. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Purified Mouse anti-Hu Actopaxin (pS8) Storage Temperature: Refrigerate(2 to 8C)...
Blank Calibration Particles, 3.0-3.4 mu m 5 ml...
Goat polyclonal to SIAH Interacting Protein ( Abpromise for all tested applications)....
Biology Products: